Literature DB >> 10639476

Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains.

T I Crean1, M John, S B Calderwood, E T Ryan.   

Abstract

The germfree mouse model of Vibrio cholerae infection can be used to judge immune responses to V. cholerae vaccine and vector strains. In the original model, a single oral inoculation was administered on day 0, a booster oral inoculation was administered on day 14, and immune responses were analyzed with samples collected on day 28. Unfortunately, immune responses in this model frequently were low level, and interanimal variability occurred. In order to improve this model, we evaluated various primary and booster V. cholerae inoculation schedules. The most prominent systemic and mucosal antibody responses were measured in mice that received a multiple primary inoculation series on days 0, 2, 4, and 6 and booster inoculations on days 28 and 42. These modifications result in improved preliminary evaluation of V. cholerae vaccine and vector strains in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639476      PMCID: PMC97235          DOI: 10.1128/IAI.68.2.977-981.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.

Authors:  C Ferreccio; M M Levine; H Rodriguez; R Contreras
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

2.  Development of a germfree mouse model of Vibrio cholerae infection.

Authors:  J R Butterton; E T Ryan; R A Shahin; S B Calderwood
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

4.  Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis.

Authors:  M B Goldberg; V J DiRita; S B Calderwood
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.

Authors:  J R Butterton; S A Boyko; S B Calderwood
Journal:  Vaccine       Date:  1993-10       Impact factor: 3.641

Review 6.  Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.

Authors:  M K Waldor; J J Mekalanos
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

7.  Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.

Authors:  W C Cray; E Tokunaga; N F Pierce
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

9.  CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor.

Authors:  G D Pearson; A Woods; S L Chiang; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.

Authors:  C O Tacket; G Losonsky; J P Nataro; L Comstock; J Michalski; R Edelman; J B Kaper; M M Levine
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

View more
  13 in total

1.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

2.  Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse.

Authors:  Ashfaqul Alam; Regina C Larocque; Jason B Harris; Cecily Vanderspurt; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Francisca Cerda; Manohar John; Jason B Harris; Regina C Larocque; Firdausi Qadri; Stephen B Calderwood; Ronald K Taylor; Edward T Ryan
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.

Authors:  Brandon Sit; Bolutife Fakoya; Ting Zhang; Gabriel Billings; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

5.  In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae.

Authors:  M John; T I Crean; S B Calderwood; E T Ryan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.

Authors:  Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

7.  Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.

Authors:  Bolutife Fakoya; Brandon Sit; Matthew K Waldor
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

8.  Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.

Authors:  A A Tarique; A Kalsy; M Arifuzzaman; S M Rollins; R C Charles; D T Leung; J B Harris; R C Larocque; A Sheikh; M S Bhuiyan; R Saksena; J D Clements; S B Calderwood; F Qadri; P Kovác; E T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

9.  The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model.

Authors:  Karla Jean Fullner; John C Boucher; Martha A Hanes; G Kenneth Haines; Brian M Meehan; Cynthia Walchle; Philippe J Sansonetti; John J Mekalanos
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

10.  Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.

Authors:  Mohammad Murshid Alam; Megan Kelly Bufano; Peng Xu; Anuj Kalsy; Y Yu; Y Wu Freeman; Tania Sultana; Md Rasheduzzaman Rashu; Ishaan Desai; Grace Eckhoff; Daniel T Leung; Richelle C Charles; Regina C LaRocque; Jason B Harris; John D Clements; Stephen B Calderwood; Firdausi Qadri; W F Vann; Pavol Kováč; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.